DC Field | Value | Language |
dc.contributor.author | Goel, Harish Chander | - |
dc.contributor.author | Laad, Poonam | - |
dc.contributor.author | Naik, Archan | - |
dc.date.accessioned | 2020-08-19T04:36:36Z | - |
dc.date.available | 2020-08-19T04:36:36Z | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 2249-9520 | - |
dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/507 | - |
dc.description.abstract | Aims and Objectives: The objective of this study was to assess the prevalence and patterns of hearing loss after concomitant radiochemotherapy in patients enrolled in a larynx preservation protocol. Materials and Methods: The study comprised of audiological evaluation of 30 patients prior to and at 1, 3, and 6 months after treatment using pure tone audiometry and impedance audiometry. Results: At the end of 6 months, 43.33% suffered sensorineural hearing loss (SNHL), 8.33% conductive hearing loss, 16.67% mixed hearing loss, and 6.67% showed improvement in hearing. Discussion: The possible mechanism for hearing loss are discussed and compared with the result of such studies in literature. Conclusion: There exist a small but definite potential risk of hearing loss after concomitant radiotherapy and chemotherapy in patients with head and neck cancer. | en_US |
dc.description.sponsorship | Audiological, , , , | en_US |
dc.language.iso | en | en_US |
dc.subject | Audiometry | en_US |
dc.subject | Head and neck cancer | en_US |
dc.subject | Concomitant radiochemotherapy | en_US |
dc.title | The Study of Auditory Effects after Concomitant Radiotherapy and Chemotherapy in Patients with Head and Neck Cancer | en_US |
dc.type | Article | en_US |
dc.journalname.journalname | Indian Journal of Otology | en_US |
dc.volumeno.volumeno | 19 | en_US |
dc.issueno.issueno | 3 | en_US |
dc.pages.pages | 136-139 | en_US |
Appears in Resource: | Journal Articles
|